1. Home
  2. CLBT vs CORT Comparison

CLBT vs CORT Comparison

Compare CLBT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$12.81

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$83.71

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
CORT
Founded
1999
1998
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
CLBT
CORT
Price
$12.81
$83.71
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$22.50
$96.50
AVG Volume (30 Days)
2.0M
955.4K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$761,407,000.00
Revenue This Year
$21.45
$26.08
Revenue Next Year
$17.47
$26.98
P/E Ratio
$45.29
N/A
Revenue Growth
N/A
12.79
52 Week Low
$11.03
$28.66
52 Week High
$19.98
$91.00

Technical Indicators

Market Signals
Indicator
CLBT
CORT
Relative Strength Index (RSI) 44.41 86.37
Support Level $12.65 $68.20
Resistance Level $13.95 $90.00
Average True Range (ATR) 0.71 3.34
MACD -0.14 0.74
Stochastic Oscillator 12.03 95.56

Price Performance

Historical Comparison
CLBT
CORT

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: